Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 31.070% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1cc(CN(C)C(=O)CC2C(=O)NCCN2Cc2ccc(F)c(F)c2)on1
b) CCN(Cc1cc2ccccc2[nH]c1=O)S(=O)(=O)c1ccccc1
Answer: a. Cc1cc(CN(C)C(=O)CC2C(=O)NCCN2Cc2ccc(F)c(F)c2)on1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(CN(C)C(=O)CC2C(=O)NCCN2Cc2ccc(F)c(F)c2)on1
Cc1cc(CN(C)C(=O)CC2C(=O)NCCN2Cc2ccc(F)c(F)c2)on1
2-[1-[(3,4-difluorophenyl)methyl]-3-oxopiperazin-2-yl]-N-methyl-N-[(3-methyl-1,2-oxazol-5-yl)methyl]acetamide